Molbio Diagnostics Ltd. makes a strong debut on the bourses with scrip got listed at Rs 980.00 on the Bombay Stock Exchange, a 21.43 per cent premium to its issue price of Rs 807.00. On the National Stock Exchange, the stock was listed at Rs 980.00.
The company, which raised 1.16 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 116.44 lakhs shares.
The company, listed under B Group Securities post its IPO, opened for subscription from Aug 10 to Aug 12.
Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE.
The company anticipates using the proceeds of the issue for .
Kotak Mahindra Capital Company Ltd.,Motilal Oswal Investment Advisors Limited,IIFL Capital Services Limited,Jefferies India Pvt. Ltd. as lead managers & KFin Technologies Ltd. is the registrar, to the issue.
Meanwhile, the broader benchmark BSE Sensex closed trade at 78,009.25, down 70.71 points, or 0.09 per cent.